Spire Healthcare Group/£SPI

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Spire Healthcare Group

Spire Healthcare Group PLC, listed under the ticker SPI, is a prominent provider of private healthcare in the United Kingdom. The company operates a network of private hospitals and clinics offering comprehensive treatment options spanning various medical fields. Founded in 2007, Spire Healthcare has established a reputation for clinical excellence and responsive patient care.

Ticker

£SPI
Sector

Primary listing

LSE

Employees

15,703

SPI Metrics

BasicAdvanced
£925M
49.97
£0.05
0.65
£0.02
1.00%

What the Analysts think about SPI

Analyst ratings (Buy, Hold, Sell) for Spire Healthcare Group stock.

Bulls say / Bears say

Spire Healthcare delivered a 4.5% year-on-year increase in H1FY2025 revenues to £796.7 million, driven by growth in both its Hospitals and Primary Care divisions, demonstrating resilient demand across its service lines. (Investegate)
In H1FY2025, adjusted EBITDA rose by 2.5% to £133.8 million, with a resilient 16.8% margin, underscoring effective cost management and operational discipline amid market headwinds. (Investegate)
Spire has engaged Rothschild & Co to explore strategic options, including a potential sale valued at over £1.4 billion (c.340p per share), which could unlock significant shareholder value at a premium to current trading levels. (FT)
Adjusted EBITDA margin in H1FY2025 contracted by 33 basis points to 16.8%, reflecting margin pressure from rising National Insurance contributions and minimum wage increases. (Investegate)
With a market capitalisation of roughly £872 million, the stock remains priced below its underlying property and asset base, indicating persistent investor scepticism about Spire’s medium-term growth prospects. (Reuters)
The initiation of a strategic review, while potentially value-accretive, introduces uncertainty and may distract management from core operations as no firm offers have been received to date. (FT)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2025.

SPI Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SPI Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £SPI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs